| Natera, Inc. Common Stock | $47.2b | $342.63 | +4.0% | 859.7K | |
| Illumina Inc | $32.2b | $207.92 | +0.9% | 1.4M | |
| Labcorp Holdings Inc. | $26.9b | $314.63 | +1.2% | 532.7K | |
| QIAGEN N.V. | $9.1b | $43.17 | -1.5% | 1.7M | |
| 10x Genomics, Inc. Class A Common Stock | $8.2b | $69.89 | +2.2% | 3.0M | |
| BillionToOne, Inc. Class A Common Stock | $4.5b | $100.92 | +2.0% | 388.1K | |
| Veracyte, Inc. | $3.6b | $40.86 | +0.8% | 790.7K | |
| GeneDx Holdings Corp. Class A Common Stock | $2.6b | $89.53 | +5.5% | 406.1K | |
| CareDx, Inc. | $2.6b | $52.56 | +4.3% | 637.3K | |
| NeoGenomics, Inc. | $2.2b | $18.43 | +6.4% | 1.2M | |
| Personalis, Inc. Common Stock | $1.8b | $16.22 | +0.5% | 1.5M | |
| Azenta, Inc. | $1.4b | $32.04 | +3.8% | 496.4K | |
| Opko Health Inc. | $1.2b | $1.53 | -1.0% | 1.8M | |
| Mesa Laboratories Inc | $0.7b | $121.00 | +0.7% | 94.9K | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $20.65 | +0.9% | 283.7K | |
| Prenetics Global Limited Class A Ordinary Share | $430.1m | $24.16 | +2.9% | 150.4K | |
| Pacific Biosciences of California, Inc. | $404.1m | $1.34 | +3.1% | 4.3M | |
| Myriad Genetics Inc | $308.9m | $3.77 | +11.4% | 2.2M | |
| Insight Molecular Diagnostics Inc. Common Stock | $131.2m | $3.99 | -3.8% | 519.1K | |
| Quantum Cyber N.V. Ordinary Shares | $127.8m | $1.33 | -1.1% | 279.9K | |
| ALPS Group Inc Ordinary Share | $63.2m | $0.40 | -1.2% | 60.6K | |
| Bionano Genomics, Inc. Common Stock | $15.0m | $1.32 | +9.8% | 393.4K | |
| BioNexus Gene Lab Corp Common stock | $4.3m | $1.50 | 0.0% | 1.6K |